The number of people with susceptibility test result for rifampicin in Gambia
Gambia: The number of people with susceptibility test result for rifampicin was 1,175 in 2021. ◆ Volatile
Latest (2021)
1,175
Change on year
up 904.3%
World rank
62nd
of 155 countries
All-time high
1,175
in 2021
All-time low
1
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Gambia, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for the number of people with susceptibility test result for rifampicin in Gambia is 1,175, measured in 2021. That is the highest value across all 5 years on record.
Compared with earlier readings it is up 904.3% on the previous year and up 117,400.0% over five years.
Gambia ranks 62nd of 155 countries on this measure, in the middle of the range.
The number of people with susceptibility test result for rifampicin in Gambia, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 1 | — |
| 2018 | 1 | +0.0% |
| 2019 | 1 | +0.0% |
| 2020 | 117 | +11600.0% |
| 2021 | 1,175 | +904.3% |
Gambia compared with similar countries
- Gambia's 1,175 is below the median for low income countries, which is 1,934, 61% of the median. (15 countries reporting)
- Gambia's 1,175 is below the median for Sub-Saharan Africa, which is 2,015, 58% of the median. (33 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 1 | 1 | 1 | 3 |
| 2020s | 646 | 117 | 1,175 | 2 |
Countries ranked near Gambia
More health data for Gambia
- Un projection of annual infant deaths, annual growth rate -1.27 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.15 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,044 deaths per 1,000 people (2090)
- Number of infants who die before age 1 700 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 0.9696 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0686 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.9636 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Gambia?
- The number of people with susceptibility test result for rifampicin in Gambia was 1,175 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Gambia?
- The highest recorded value was 1,175 in 2021.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Gambia?
- The lowest recorded value was 1 in 2017.
- How does Gambia rank for the number of people with susceptibility test result for rifampicin?
- Gambia ranks 62nd out of 155 countries with data for 2021.
- Where does this Gambia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).